Women treated with antimuscarinics for overactive bladder syndrome are more likely to be diagnosed with depression after treatment onset than overactive bladder patients not treated with the ...
—Maybe, say the results of a UK meta-analysis, which found some patients to benefit from the alternative approach. Considering the side effects of certain OAB medications and poor adherence, it’s ...
Author(s)C. Daniel Mullins, PhD, Leslee L. Subak, MD Clinicians can play an important role ineducating patients about their health condition,treatment options, and disease management.Prospective ...
The American Urologic Association advises caution in the use of anticholinergic medications to treat older or frail adults with OAB. Despite an increased risk of cognitive decline associated with ...
HealthDay News — For older adults starting antimuscarinic treatment for overactive bladder (OAB), potentially inappropriate medication (PIM) use is highly prevalent and associated with greater total ...
Women treated with the overactive bladder medication mirabegron experienced rises in brown adipose tissue metabolic activity as well as insulin sensitivity, resting energy expenditure and other ...
PITTSBURGH, Dec. 18, 2025 /PRNewswire/ -- A new retrospective study published in the International Urogynecology Journal (DOI: 10.1007/s00192-025-06209-8) by researchers at Allegheny Health Network's ...
Overactive bladder is most common in adults over 65 but can also be due to hormonal changes. Maintaining a healthy weight, eating right, and staying hydrated can help control surprise leaks. If ...
After two-plus years of quarantines and travel restrictions, it’s no surprise many of us are making up for lost time, booking trips and scheduling long-overdue visits with friends and loved ones.
Q: I have overactive bladder. My doctor prescribed a new drug called Myrbetriq (mirabegron). Instead of being an anticholinergic drug like most other bladder medicines, it works through beta receptors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback